Bocker T, Diermann J, Friedl W, Gebert J, Holinski-Feder E, Karner-Hanusch J, von Knebel-Doeberitz M, Koelble K, Moeslein G, Schackert H K, Wirtz H C, Fishel R, Rüschoff J
Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
Cancer Res. 1997 Nov 1;57(21):4739-43.
The molecular biology section of the Hereditary Non-Polyposis Colorectal Cancer study group-Germany, instituted a multicenter study to test the reliability and quality of microsatellite instability (MSI) analysis. Eight laboratories compared MSI analyses performed on 10 matched pairs of normal and tumor DNA from patients with colorectal carcinomas. A variety of techniques were applied to the detection of microsatellite changes: (a) silver and ethidium bromide staining of polyacrylamide gels; (b) radioactive labeling; and (c) automated fluorescence detection. The identification of highly unstable tumors and tumors without MSI was achieved in high concordance. However, the interpretation of the band patterns resulted in divergent classifications at several microsatellite marker loci for a large fraction of this tumor/normal panel. The data on more than 30 primers per case suggest that the enlargement of the microsatellite panel to more than 10 loci does not influence the results. In this study, cases with MSI in less than 10% of loci were classified as microsatellite stable, whereas MSI was diagnosed in cases with more than 40% of all markers unstable. We propose that a panel of five microsatellite loci consisting of repeats with different lengths should be analyzed in an initial analysis. When less than two marker loci display shifts in the microsatellite bands from tumor DNA, the panel should be enlarged to include an additional set of five marker loci. The number of marker loci analyzed as well as the number of unstable marker loci found should always be identified. These criteria should result in reports of MSI that are more comparable between studies.
德国遗传性非息肉病性结直肠癌研究小组的分子生物学部门开展了一项多中心研究,以测试微卫星不稳定性(MSI)分析的可靠性和质量。八个实验室对来自结直肠癌患者的10对匹配的正常和肿瘤DNA样本进行了MSI分析比较。采用了多种技术来检测微卫星变化:(a)聚丙烯酰胺凝胶的银染和溴化乙锭染色;(b)放射性标记;(c)自动荧光检测。高度不稳定肿瘤和无MSI肿瘤的识别具有高度一致性。然而,对于该肿瘤/正常样本的很大一部分,在几个微卫星标记位点上,条带模式的解读导致了不同的分类。每个病例使用30多种引物的数据表明,将微卫星检测板扩大到10个以上位点不会影响结果。在本研究中,微卫星位点不稳定比例低于10%的病例被分类为微卫星稳定,而所有标记中超过40%不稳定的病例被诊断为MSI。我们建议在初始分析中分析一组由不同长度重复序列组成的五个微卫星位点。当肿瘤DNA的微卫星条带中少于两个标记位点出现移位时,检测板应扩大,增加另外一组五个标记位点。应始终明确分析的标记位点数以及发现的不稳定标记位点数。这些标准应能使不同研究之间关于MSI的报告更具可比性。